Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability
- PMID: 25921660
- PMCID: PMC4712629
- DOI: 10.1016/j.cld.2015.01.001
Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability
Abstract
Liver cancer is the second leading cause of global cancer mortality. The major risk factors for hepatocellular carcinoma (HCC) are being addressed with success by prevention efforts. Vaccination against hepatitis B virus has reduced incidence of HCC in Taiwan and is partly responsible for lower rates in China. New infections with hepatitis C virus are low in developed countries because of prevention of posttransfusion infections and reduced exposure to HCV by drug users. Aflatoxin exposure has been reduced by better grain storage and dietary changes. Obesity, metabolic syndrome, and diabetes are increasing in developed and developing countries and will lead to more cases of HCC.
Keywords: Aflatoxin; Alcohol; Chemoprevention; Coffee; Diabetes; Hepatitis B virus; Hepatitis C virus; Incidence.
Published by Elsevier Inc.
Conflict of interest statement
The authors have no conflicts to disclose.
Figures




References
-
- Ferlay J, Parkin DM, Curado MP, et al. Cancer incidence in five continents, volumes I to X: IARC CANCERBase No. 10. [Accessed November 25, 2014];2014 [Internet]. Available at: http://ci5.iarc.fr.
-
- Ferlay J, Soerjomataram I, Ervik M, et al. Lyon, France: International Agency for Research on Cancer; 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. [Internet] Available from: http://globocan.iarc.fr. 2014.
-
- Tanaka H, Imai Y, Hiramatsu N, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148(11):820–826. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical